Exact Sciences supplies Oncotype DX tests to Norfolk and Norwich hospitals
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- East of England
- Call-off from a framework agreement
- 27 February 2026 to 31 March 2027
Norfolk and Norwich University Hospitals NHS Foundation Trust buys Oncotype DX Breast Recurrence Score tests from Exact Sciences. The tests help clinicians judge the risk of a breast cancer coming back and whether chemotherapy is likely to help.
The trust placed the order as a call-off from a framework in February 2026. The £315,600 contract runs to March 2027.
Contract ends March 2027
- What
- Pathology and specialist laboratory testing services
- Supplier
- Exact Sciences
- Value
- £315,600
- How it was bought
- Call-off from a framework agreement
- Dates and next
- Feb 2026 to Mar 2027